Which GLP-1 drug will have the highest US market share by revenue on December 1, 2025?
4
Ṁ125Ṁ140resolved Dec 2
100%4%
Zepbound
83%
Ozempic
4%
Wegovy
4%
Mounjaro
4%Other
This question is managed and resolved by Manifold.
Market context
Get 
1,000 to start trading!
1,000🏅 Top traders
| # | Trader | Total profit |
|---|---|---|
| 1 | Ṁ5 |
Sort by:
Resolved:
People are also trading
Related questions
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
Will a majority government owned company introduce a new GLP-1 drug before 2040?
15% chance
What fraction of US adults will regularly take GLP-1 drugs in 2030?
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
86% chance
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
10% chance
Will Ozempic/GLP-1 Agonists become an issue with a clear partisan divide in the US in the next 5 years?
45% chance
[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...
By 2029, will there be an FDA approval of GLP-1 for a substance use disorder?
86% chance
Nobel Prize awarded for Ozempic (or GLP-1 drugs) by 2030?
38% chance
Which of these protein targets will have at least one new drug targeting them receive FDA approval between 2025 and 2030